Cobblestone Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $911K | Buy |
20,188
+137
| +0.7% | +$6.4K | 0.04% | 150 |
|
|
2025
Q2 | $928K | Sell |
20,051
-851
| -4% | -$41.8K | 0.05% | 147 |
|
|
2025
Q1 | $1.27M | Sell |
20,902
-197
| -0.9% | -$11.5K | 0.07% | 123 |
|
|
2024
Q4 | $1.19M | Sell |
21,099
-204
| -1% | -$11.4K | 0.07% | 121 |
|
|
2024
Q3 | $1.1M | Buy |
21,303
+355
| +2% | +$16.7K | 0.06% | 129 |
|
|
2024
Q2 | $870K | Sell |
20,948
-804
| -4% | -$36K | 0.05% | 138 |
|
|
2024
Q1 | $1.18M | Sell |
21,752
-1,155
| -5% | -$58.8K | 0.07% | 112 |
|
|
2023
Q4 | $1.18M | Buy |
22,907
+3,997
| +21% | +$210K | 0.08% | 114 |
|
|
2023
Q3 | $1.1M | Sell |
18,910
-2,593
| -12% | -$159K | 0.08% | 103 |
|
|
2023
Q2 | $1.38M | Sell |
21,503
-5,900
| -22% | -$396K | 0.1% | 95 |
|
|
2023
Q1 | $1.9M | Buy |
27,403
+6,164
| +29% | +$435K | 0.14% | 77 |
|
|
2022
Q4 | $1.53M | Buy |
21,239
+195
| +0.9% | +$14.7K | 0.12% | 88 |
|
|
2022
Q3 | $1.5M | Sell |
21,044
-515
| -2% | -$37.4K | 0.12% | 77 |
|
|
2022
Q2 | $1.66M | Sell |
21,559
-1,280
| -6% | -$97.5K | 0.13% | 78 |
|
|
2022
Q1 | $1.67M | Sell |
22,839
-665
| -3% | -$44.7K | 0.11% | 85 |
|
|
2021
Q4 | $1.47M | Buy |
23,504
+561
| +2% | +$32.9K | 0.09% | 103 |
|
|
2021
Q3 | $1.36M | Sell |
22,943
-701
| -3% | -$46.2K | 0.09% | 97 |
|
|
2021
Q2 | $1.58M | Sell |
23,644
-2,970
| -11% | -$194K | 0.11% | 90 |
|
|
2021
Q1 | $1.68M | Buy |
26,614
+740
| +3% | +$46K | 0.12% | 85 |
|
|
2020
Q4 | $1.6M | Buy |
25,874
+15
| +0.1% | +$922 | 0.12% | 79 |
|
|
2020
Q3 | $1.56M | Buy |
25,859
+77
| +0.3% | +$4.63K | 0.13% | 80 |
|
|
2020
Q2 | $1.52M | Sell |
25,782
-2,125
| -8% | -$127K | 0.14% | 76 |
|
|
2020
Q1 | $1.56M | Buy |
27,907
+2,273
| +9% | +$139K | 0.17% | 70 |
|
|
2019
Q4 | $1.65M | Buy |
25,634
+11,912
| +87% | +$682K | 0.15% | 75 |
|
|
2019
Q3 | $696K | Sell |
13,722
-4,424
| -24% | -$208K | 0.07% | 121 |
|
|
2019
Q2 | $823K | Sell |
18,146
-807
| -4% | -$37.6K | 0.07% | 116 |
|
|
2019
Q1 | $904K | Buy |
18,953
+1,517
| +9% | +$75.6K | 0.08% | 103 |
|
|
2018
Q4 | $906K | Sell |
17,436
-556
| -3% | -$29.9K | 0.09% | 96 |
|
|
2018
Q3 | $1.12M | Buy |
17,992
+279
| +2% | +$16.6K | 0.11% | 88 |
|
|
2018
Q2 | $980K | Sell |
17,713
-61
| -0.3% | -$3.29K | 0.1% | 95 |
|
|
2018
Q1 | $1.12M | Buy |
17,774
+462
| +3% | +$29.7K | 0.11% | 89 |
|
|
2017
Q4 | $1.06M | Buy |
17,312
+399
| +2% | +$25K | 0.11% | 97 |
|
|
2017
Q3 | $1.08M | Buy |
16,913
+4,518
| +36% | +$264K | 0.13% | 78 |
|
|
2017
Q2 | $691K | Sell |
12,395
-884
| -7% | -$48.1K | 0.09% | 101 |
|
|
2017
Q1 | $722K | Buy |
13,279
+3,690
| +38% | +$202K | 0.1% | 101 |
|
|
2016
Q4 | $560K | Buy |
9,589
+3,497
| +57% | +$191K | 0.08% | 116 |
|
|
2016
Q3 | $328K | Sell |
6,092
-410
| -6% | -$26.3K | 0.05% | 148 |
|
|
2016
Q2 | $478K | Sell |
6,502
-112
| -2% | -$7.91K | 0.07% | 126 |
|
|
2016
Q1 | $423K | Sell |
6,614
-10
| -0.2% | -$631 | 0.06% | 136 |
|
|
2015
Q4 | $456K | Buy |
6,624
+1,314
| +25% | +$86.8K | 0.07% | 135 |
|
|
2015
Q3 | $314K | Sell |
5,310
-849
| -14% | -$53.9K | 0.05% | 144 |
|
|
2015
Q2 | $410K | Buy |
6,159
+508
| +9% | +$33.5K | 0.06% | 127 |
|
|
2015
Q1 | $364K | Sell |
5,651
-234
| -4% | -$14.6K | 0.06% | 133 |
|
|
2014
Q4 | $347K | Hold |
5,885
| – | – | 0.06% | 133 |
|
|
2014
Q3 | $301K | Buy |
5,885
+152
| +3% | +$7.59K | 0.06% | 131 |
|
|
2014
Q2 | $278K | Sell |
5,733
-38
| -0.7% | -$1.87K | 0.05% | 137 |
|
|
2014
Q1 | $300K | Sell |
5,771
-984
| -15% | -$52.4K | 0.06% | 131 |
|
|
2013
Q4 | $359K | Buy |
6,755
+44
| +0.7% | +$2.24K | 0.07% | 127 |
|
|
2013
Q3 | $311K | Buy |
6,711
+82
| +1% | +$3.6K | 0.06% | 122 |
|
|
2013
Q2 | $296K | Buy |
+6,629
| New | +$288K | 0.07% | 124 |
|
Other funds holding BMY
Cobblestone Capital Advisors's BMY Position: Q3 2025 in Review
Cobblestone Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.68% in Q3 2025, buying an estimated $6.4K and bringing the position to 20,188 shares worth $911K. The position accounts for 0.04% of the portfolio, ranked #150.
Cobblestone Capital Advisors first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.9M in Q1 2023. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Cobblestone Capital Advisors held 20,188 shares of Bristol-Myers Squibb worth $911K as of Q3 2025.
- Cobblestone Capital Advisors bought 137 Bristol-Myers Squibb shares in Q3 2025, an estimated $6.4K.
- Bristol-Myers Squibb made up 0.04% of Cobblestone Capital Advisors's portfolio in Q3 2025, its #150 holding.
- Cobblestone Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
- Cobblestone Capital Advisors's Bristol-Myers Squibb position peaked at $1.9M in Q1 2023.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Cobblestone Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.